MedTrace Logo

Toxicities of Cervix and Corpus Uteri Carcinomas Treatment and Evaluation of Impact on Sexual Function

NCT01650987 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2016-08-08

No results posted yet for this study

Summary

Evaluate the toxicities of cervix and corpus uteri carcinomas treatment

Conditions

  • Corpus Uteri Carcinoma

Sponsors & Collaborators

  • Centre Oscar Lambret

    lead OTHER

Principal Investigators

  • Philippe NICKERS, MD · Oscar Lambret Center

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2015-05-31
Completion
2015-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01650987 on ClinicalTrials.gov